Key statistics
On Thursday, Recursion Pharmaceuticals Inc (RXRX:BRN) closed at 2.85, 0.00% above its 52-week low of 2.85, set on Feb 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.85 |
|---|---|
| High | 2.85 |
| Low | 2.85 |
| Bid | 2.71 |
| Offer | 2.73 |
| Previous close | 2.85 |
| Average volume | 700.00 |
|---|---|
| Shares outstanding | 519.84m |
| Free float | 491.33m |
| P/E (TTM) | -- |
| Market cap | 1.81bn USD |
| EPS (TTM) | -1.81 USD |
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
- Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
- Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
- Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
- Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
- Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
- Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
- Recursion to Participate in Upcoming Investor Conferences
- Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
- Recursion to Participate in Upcoming Investor Conferences
- Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
More ▼
